AstraZeneca PLC (AZN)

AstraZeneca Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4,797	5,840	6,166	6,329	7,832	5,369
Short-Term Investments	133	-	64	53	42	38
Trading Asset Securities	-	20	14	16	161	811
Cash & Short-Term Investments	4,930	5,860	6,244	6,398	8,035	6,218
Cash Growth	-3.62%	-6.15%	-2.41%	-20.37%	29.22%	9.47%
Accounts Receivable	11,879	8,407	7,212	6,031	3,806	3,585
Other Receivables	1,668	3,528	2,711	2,764	1,845	1,596
Receivables	13,547	11,935	9,923	8,795	5,651	5,181
Inventory	5,662	5,424	4,699	8,983	4,024	3,193
Prepaid Expenses	-	1,617	1,329	1,512	1,735	865
Restricted Cash	-	102	162	-	-	-
Other Current Assets	16	116	236	556	99	106
Total Current Assets	24,155	25,054	22,593	26,244	19,544	15,563
Property, Plant & Equipment	11,513	10,502	9,449	10,171	8,917	8,335
Long-Term Investments	2,145	1,777	1,142	1,262	1,192	1,512
Goodwill	21,139	20,048	19,820	19,997	11,845	11,668
Other Intangible Assets	39,394	38,089	39,307	42,387	20,947	20,833
Long-Term Deferred Tax Assets	5,342	4,718	3,263	4,330	3,438	2,718
Other Long-Term Assets	1,234	931	909	972	846	748
Total Assets	104,922	101,119	96,483	105,363	66,729	61,377
Accounts Payable	21,684	3,267	2,550	2,824	2,350	1,774
Accrued Expenses	-	15,743	13,427	12,358	9,689	9,398
Short-Term Debt	1,241	5,129	5,314	411	661	225
Current Portion of Long-Term Debt	29	989	960	2,248	1,566	1,633
Current Portion of Leases	317	271	228	233	192	188
Current Income Taxes Payable	1,468	1,584	896	916	1,127	1,361
Current Unearned Revenue	-	251	269	1,181	1,958	125
Other Current Liabilities	1,187	3,308	2,649	2,423	2,764	3,413
Total Current Liabilities	25,926	30,542	26,293	22,594	20,307	18,117
Long-Term Debt	28,921	22,403	23,908	29,717	19,804	17,894
Long-Term Leases	1,105	857	725	754	489	487
Long-Term Unearned Revenue	-	7	14	26	38	50
Long-Term Deferred Tax Liabilities	3,568	2,844	2,944	6,206	2,918	2,490
Other Long-Term Liabilities	3,236	3,780	4,373	4,325	4,333	4,936
Total Liabilities	64,117	61,953	59,425	66,076	51,091	46,781
Common Stock	388	388	387	387	328	328
Additional Paid-In Capital	35,203	35,188	35,155	35,126	7,971	7,941
Retained Earnings	3,138	4,516	3,120	3,644	6,442	5,001
Comprehensive Income & Other	1,990	-949	-1,625	111	881	-143
Total Common Equity	40,719	39,143	37,037	39,268	15,622	13,127
Minority Interest	86	23	21	19	16	1,469
Shareholders' Equity	40,805	39,166	37,058	39,287	15,638	14,596
Total Liabilities & Equity	104,922	101,119	96,483	105,363	66,729	61,377
Total Debt	31,613	29,649	31,135	33,363	22,712	20,427
Net Cash (Debt)	-26,683	-23,789	-24,891	-26,965	-14,677	-14,209
Net Cash Per Share	-17.07	-15.23	-15.96	-18.90	-11.18	-10.92
Filing Date Shares Outstanding	1,550	1,550	1,550	1,549	1,313	1,312
Total Common Shares Outstanding	1,550	1,550	1,550	1,549	1,313	1,312
Working Capital	-1,771	-5,488	-3,700	3,650	-763	-2,554
Book Value Per Share	26.27	25.25	23.90	25.34	11.90	10.00
Tangible Book Value	-19,814	-18,994	-22,090	-23,116	-17,170	-19,374
Tangible Book Value Per Share	-12.78	-12.25	-14.25	-14.92	-13.08	-14.77
Land	-	6,469	5,440	6,377	5,851	5,532
Machinery	-	8,704	7,556	7,903	7,738	7,383
Construction In Progress	-	2,045	2,653	2,728	2,478	2,086

Source: S&P Capital IQ. Standard template. Financial Sources.